To the General Assembly in Carasent ASA
PROPOSAL FOR ELECTION OF BOARD DIRECTORS AT THE 2023 ANNUAL SHAREHOLDER MEETING
The current Nomination Committee of Carasent ASA was elected by the Carasent shareholder meeting on April 28, 2022.
The Committee has performed an assessment of the Board in light of the Company's needs, as well as concluded discussions with the Company's largest shareholders. The Board Director Terje Rogne has decided to step down after 15 years as Board Director. The other Board Directors including the Chairman of the Board, have only served for less than one period, except Staffan Hanstorp whose first term ends in June 2023. The Nomination Committee has concluded that there is no need for major changes in the Board. It is proposed that Staffan Hanstorp is re-elected for a new 2-year term and that the alternate Board Director Tomas Meerits replaces Terje Rogne as permanent Board Director for a 2- year term. The Carasent ASA 2023 Annual Shareholder Meeting is scheduled for May 3, 2023. The Calling Notice with proposed resolutions will be posted by the Company at least 3 weeks in advance of the meeting.
The proposal from the Nomination Committee
Name | Position | 1st elected | Current election term | Proposal | |
Petri Nemi | Chairman | 2022 | October 19, 2022 for 2 years | Continue | |
Terje Rogne | Member | 2007 | June 30, 2021 for 2 years | Replaced | |
Staffan Hanstorp | Member | 2021 | June 30, 2021 for 2 years | Re-elected | |
Camilla Skog | Member | 2022 | April 28, 2022 for 2 years | Continue | |
Ulrika Cederskog | Member | 2022 | April 28, 2022 for 2 years | Continue | |
Sundling | |||||
Tomas Meerits | Alternate | 2021 | October 27, 2021 for 2 years | Elected as Board | |
member | member | ||||
Board shareholdings and independence | |||||
Name | Position | Shareholding | Independence | ||
Petri Niemi | Chairman | 12 264 | Independent | ||
Terje Rogne | Member | 500 000 | Independent | ||
Staffan Hanstorp | Member | - | Aeternum Capital AS | ||
Ulrika Cederskog | Member | - | Independent | ||
Sundling | |||||
Camilla Skoog | Member | - | Independent | ||
Tomas Meerits | Alternate | - | Vitruvian Partners | ||
member |
Aeternum Capital AS controls directly and indirectly 10 450 000 shares representing 13.14% of total number of shares.
Vitruvian Partners controls directly and indirectly 11 987 332 shares representing 15.08% of total number of shares.
___________________________________________________________________________________________
Carasent Nomination Committee proposal to the 2023 Annual Shareholder Meeting
Board independence
Based on the proposed composition of the Board, all the Directors will be independent in relation to the Company and its management. The majority of the Directors will be independent in relation to major shareholders.
Vitruvian Partners, Aeternum Capital AS and the group of Carasent founders represented in the Nomination Committee who support the proposal, together represent 41% of the shares in Carasent ASA.
Board remuneration
The Nomination Committee has reviewed the Board fees in light of responsibilities, expected workload and market conditions. It is proposed that the remuneration is kept unchanged which means NOK 500,000 to the Chairman of the Board and NOK 250,000 to each Director.
The Nomination Committee of Carasent ASA
Oslo, December 22, 2022
Sign. | Sign. | Sign. |
.............................................. | .......................................... ........................................ | |
Henrik Carlman | Niclas Hugosson | Niclas Lindlöf |
___________________________________________________________________________________________
Carasent Nomination Committee proposal to the 2023 Annual Shareholder Meeting
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Carasent ASA published this content on 19 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 February 2023 14:56:04 UTC.